Brief: Oasmia Transfers Nordic Commercialization Rights For Apealea To Inceptua
June 28 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA TRANSFERS NORDIC COMMERCIALIZATION RIGHTS FOR
APEALEA® TO
INCEPTUA
* AGREEMENT TO TRANSFER RIGHTS FOR COMMERCIALIZATION OF
APEALEA IN
NORDICS AND BALTICS TO INCEPTUA GROUP
Source text for Eikon: ID:nMFNbPkmSm
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO